-
@ English News
2025-05-07 06:06:55Arbutus Presents Clinical Trial Data from its Two HBV Assets, Imdusiran and AB-101, at the European Association for the Study of the Liver (EASL) Congress 2025 https://financialpost.com/globe-newswire/arbutus-presents-clinical-trial-data-from-its-two-hbv-assets-imdusiran-and-ab-101-at-the-european-association-for-the-study-of-the-liver-easl-congress-2025